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and Growth Factors: Ephrins
Enter the Fray at the Border
of Angiopoietin-2, the natural antagonist for Tie2 (Mai-
sonpierre et al., 1997), all lead to embryonic lethality
resulting from defects in angiogenesis.
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and eight ephrin ligands for these receptors have beenBoston, Massachusetts 02115
described to date. The Eph receptors and their ligands
can broadly be divided into two subclasses, A and B,
In an important paper in this issue of Cell, David Ander- based on structural homologies and binding specifici-
son and his associates provide insights into the early ties, with a great deal of redundancy within a subclass
molecular determinants that distinguish arteries and in terms of receptor/ligand binding specificities (Gale
veins (Wang et al., 1998). The key players include the et al., 1996; Flanagan and Vanderhaeghen, 1998). The
Eph-B4 receptor from theEph familyÐthe largest known ephrin-B ligands are transmembrane proteins and pref-
family of receptor tyrosine kinasesÐand its obligate erentially bind to receptors of the Eph-B subclass. Unlike
membrane-bound ligand, ephrin-B2. Wang et al. also ligands for other receptor tyrosine kinases, the ephrins
link the actions of ephrin-B2 and Eph-B4 to those of a can not act as soluble mediators, but rather must be
recently defined family of angiogenic factors, the angio- membrane-bound in order to activate their receptors
poietins, and their endothelial-specific receptor tyrosine (membrane linkage seemingly serves to cluster the li-
kinases, the Ties. gands, and this clustering is required for their activity)
Vasculogenesis Versus Angiogenesis, (Davis et al., 1994). Remarkably, there appears to be
and Their Molecular Regulators reciprocal signaling between ligands and receptors in
The adult vasculature consists of large arteries, inter- the B subclass, in that ephrin-B ligands not only activate
nally lined by endothelial cells and well-ensheathed by their respective receptors, but are in turn activated upon
smooth muscle cells, that progressively branch into engaging their receptors, as judged by tyrosine phos-
phorylation of the ephrin-B cytoplasmic domains (Bruck-smaller and smaller vessels, terminating in precapillary
ner et al., 1997; Holland et al., 1997). These findingsarterioles that then give rise to capillaries. Capillaries
suggested early on that the ephrins might provide keyare comprised almost entirely of endothelial cells that
bidirectional cues in an obligate cell-to-cell contact-are only occasionally coated by a smooth muscle cell-
dependent fashion.like pericyte.Capillaries then feed into postcapillary ven-
The ephrins and their Eph receptors have been mostules that progressively associate into larger and larger
studied for their roles in the nervous system. Most nota-venous structures. The earliest stages of vascular devel-
bly, they seem to help guide axons by mediating repul-opment, termed vasculogenesis, include the differentia-
sive cues, and they also seem to maintain borders be-tion, expansion, and coalescence of vascular endothe-
tween distinct neuronal compartments by preventinglial cell precursors into the initial vascular network
cell mixing (Flanagan and Vanderhaeghen, 1998). A more(Risau, 1995). This initial lattice consists purely of endo-
general role for the Eph family during formation of manythelial cells that have formed rather homogenously sized
different embryonic boundaries was proposed basedinterconnected vessels, and has thus been referred to
on the observation that ephrins and their receptors wereas the primary capillary plexus (Figure 1, left panel). The
found in reciprocal compartments throughout the devel-primary plexus is then remodeled by a process referred
oping embryo, with receptors and ligands in contact
to as angiogenesis (Risau, 1995), which involves the
only at the boundaries of these compartments (Gale etsprouting, branching and differential growth of blood
al., 1996). In addition, a variety of findings had suggested
vessels to form the more mature appearing vascular
roles for the Eph family in the vasculature (e.g., Stein et
patterns seen in the adult organism (Figure 1, right al., 1998). The manuscript by Wang et al. should shift
panel). Angiogenesis also involves differential recruit- the focus of Eph biologists more to the vasculature by
ment of associated supporting cells, such as smooth suggesting that members of the Eph family are involved
muscle cells and pericytes, to different segments of the in a very particular vascular boundary, that between
vasculature (Folkman and D'Amore, 1996). arteries and veins.
Gene knockout studies have demonstrated that the The Eph Family Distinctly Marks Arteries and Veins
earliest phases of vasculogenesis require VEGF and one The entire vascular system must be in place in the em-
of its endothelial cell-specific receptors, termed VEGFR2 bryo before the heart starts to beat, but until the findings
(Shalaby et al., 1995; Carmeliet et al., 1996; Ferrara et of Wang et al., the genetic program that apportions the
al., 1996). In contrast, the more recently discovered angi- venous capacity to the size of the arterial tree prior to
opoietins (Davis et al., 1996; Maisonpierre et al., 1997) blood flow had remained completely mysterious. Wang
do not seem to be important for vasculogenesis but et al. report that ephrin-B2 marks future arterial but not
instead act during angiogenesis. Disruption of thegenes venous endothelial cells, while one of the receptors for
for Tie2 (Sato et al., 1995) or its activating ligand Angio- ephrin-B2 (i.e., Eph-B4) reciprocally marks the venous
poietin-1 (Suri et al., 1996), or transgenic overexpression endothelium, at the earliest stages of capillary plexus
formation, at a point when it had been assumed all endo-
thelium was rather uniform in nature. These reciprocal
expression patterns not only provide the earliest known³To whom correspondence should be addressed.
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Figure 1. Presumed Distributions and Sites of Action of ephrin-B2 and Eph-B4 in the Primary Capillary Plexus and during Later Maturation
of the Vascular Network
Wang et al. define ephrin-B2 and Eph-B4 as a ligand/receptor pair that distinguish arterial as opposed to venous endothelial cells in the
otherwise homogenous primary capillary plexus; since both ephrin-B2 and Eph-B4 act only as membrane-bound proteins, they presumably
interact with each other only at the junction of the arterial and venous endothelial cells, in what we term a ªcisº manner (left panel). The
primary plexus is remodeled by angiogenic processes involving the interdigitation, branching, and differential growth of vessel segments.
During these remodeling stages ephrin-B2 and Eph-B4 remain localized to arterial and venous endothelial cells, respectively. They presumably
continue to interact at junctions of small branches (future capillaries) joining the arterial and venous systems (labeled as CIS interactions),
but they may also interact at the surfaces between interdigitating large vessels as they pass each other (labeled as Trans interactions) (right
panel). Other growth factors acting on endothelial cells, such as VEGF and Angiopoietin-1, appear to be acting more symmetrically. VEGF is
required for formation of the primary capillary plexus, while ephrin-B2 and Angiopoietins instead are required during angiogenic remodeling.
See text for more details.
markers distinguishing arterial and venous endothelium, nervous system. Similarly, local interactions may ensure
that new branches sprouting from the existing networkbut suggest that some sort of bidirectional signaling is
occurring between these sets of cells. Consistent with fuse only with counterpart branches expressing com-
plementary Eph partners, so that arterial capillariesthis notion, Wang et al. report that embryonic mice ho-
mozygous for a null mutation in ephrin-B2 reveal defects connect only to the venous system. Alternatively, mutu-
ally inhibitory interactions between ligand- and recep-in angiogenesis that occur in the vascular networks of
the head and yolk sac, indicating that reciprocal signal- tor-expressing cells may insure that fusion of smaller
vessels to generate larger ones during remodeling oc-ing between presumptive arteries and veins is indeed
required for proper morphogenesis of the intervening curs only between ªlikeº capillaries, thereby preventing
intermixing of arterial and venous vessels. ªcisº signal-capillary beds as well as for interdigitation and differen-
tial growth of the larger vessels themselves. ing may have more complex actions, for example pre-
venting junctional portions of vascular segments fromBut how are ephrin-B2 and its receptor acting during
vascular development? At early stages in vascular de- enlarging into larger arterial or venous structures, ensur-
ing that they instead differentiate so as to comprise thevelopment, it seems likely that ligand and receptor are
engaged in ªcisº configuration, i.e., between neigh- intervening microvasculature. Concerning ªtransº inter-
actions, it may be easiest to imagine that they mayboring arterial and venous cells within the walls of a
continuous capillary segment (Figure 1, left and right be promoting the interdigitation of growing arterial and
venous vessels, which are absent in the ephrin-B2 knock-panels). They may also interact in ªtransº, i.e., arterial
cells in one vessel interacting with venous cells from an out, perhaps by allowing complementary vessels to
crawl along each other prior to putting out interconnect-adjacent vascular segment (Figure 1, right panel). It is
easy to imagine that disruption of either type of interac- ing branches; ªtransº interactions may somehow even
prevent large vessels from inappropriately fusing in thetion may lead to the observed defects in subsequent
remodeling. One also wonders whether key signals are absence of smaller branches, perhaps by providing re-
pulsive cues. In any case, while some of these proposedtransmitted locally only between the directly interacting
cells, or whether receptor±ligand engagement by these actions of ephrin-B2 engagement by Eph-B4 are seem-
ingly analogous to those previously proposed for thecells somehow leads to propagation of secondary sig-
nals to cells in the rest of the plexus. ªcisº interactions Eph family in axon guidance or boundary formation, Eph
actions on the vasculature may prove fundamentallymay act locally to form a boundary that simply prevents
cell intermixing, consistent with Eph actions seen in the different from those in the developing nervous system.
Minireview
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Sharing of Molecular Determinants by Neuronal that this reciprocal demarcation occurs in the adult vas-
culature as well. Markers of sharp boundaries betweenGuidance and Angiogenesis
It is intriguing to note that the discovery of the ephrin- the adult arterial and venous circulations have pre-
viously been defined (Thurston et al., 1996), and theB2/Eph-B4 role in angiogenesis follows the recent find-
ing that another mediator of axonal repulsion in the ner- ephrin system may well be involved in these very same
boundaries. Interestingly, these boundaries are per-vous system, neuropilin-1, in addition seems to play a
key role during angiogenesis by serving as a coreceptor turbed in angiogenic situations in the adult, as capillary/
venule borders begin to blur. In any case, further under-for a form of VEGF (Soker et al., 1998). As noted,
transgenic overexpression or targeted disruption of the standing of the role of ephrins in developmental angio-
genesis, and determination of whether ephrins repriseneuropilin-1 gene resulted in abnormalities in the cardio-
vascular system in addition to those in the nervous sys- this role in settings of adult neovascularization, may help
in ongoing therapeutic efforts aimed at either blockingtem (Soker et al., 1998). For both neuropilin-1 and mem-
bers of the Eph family, it remains unclear if their nervous angiogenesis in pathological processes dependent on
new angiogenesis, such as in tumors or inflammation,system actions can be mechanistically related to their
or promoting angiogenesis in adult settings of ischemia.roles during blood vessel development.
For example, when individual capillary sprouts convergeEphrin-B2 Knockout Resembles Those
on a tumor implanted in the rabbit or murine cornea,of Angiopoietin-1 and Tie2
they appear to join to form microvascular loops, afterOne of the striking features of the ephrin-B2 knockout
which flow can be observed; the diameter of the efferentphenotype is its similarity to that of the mice in which
arm of a loop (the venous side) can be readily distin-Angiopoietin-1/Tie2 signaling has been disrupted. In
guished morphologically because it is wider than theboth cases, angiogenic remodeling is markedly per-
afferent arm. Similar fusion of sprouts into loops can beturbed, while primary vasculogenesis is largely unaf-
convincingly demonstrated in models in which nylonfected. Another major similarity in all these mice involves
meshes covering collagen gels containing bFGF aredefects in heart development marked by the absence
placed on the surface of the chick chorioallantoic mem-of myocardial infoldings, known as trabeculae. A similar
brane, forcing individual sprouts to grow verticallyheart defect was also reported in mice lacking neuregu-
through the mesh and then fuse (Nguyen et al., 1994).lin or its receptor, which had led to the proposal of
We can now ask if the ephrin-B2 ligand is expressed bya required growth factor loop in trabecular formation
the afferent arm of the capillary loop, and its receptorinvolving both an endocardial-derived ligand acting on
on the efferent arm. If so, what would be the effect ofthe myocardium, i.e., neuregulin, and a myocardial-
blocking these proteins?derived factor acting on the endocardium, i.e., Angio-
In other forms of vascular growth that occur in thepoietin-1 (Suri et al., 1996). The realization that ephrin-
postnatal or adult periods, there are unresolved ques-B2 is also involved in this process adds another player
tions that appear to depend upon a poorly understoodto the model, but our inability even to assign a sequence
conversation between arteries and veins. For example,to the actions of these players emphasizes how little we
why do collateral arteries form at a considerable dis-understand about the process of trabecular formation.
tance from the ischemic capillary bed that they supply?Likewise, despite the similiarities between the angio-
Why does experimental occlusion of either the coronarygenic remodeling defects resulting from disruption of
artery or the renal artery lead to increased 3H-thymidineeither ephrin or angiopoietin signaling, it remains difficult
labeling not only in the growing collaterals (arteriogene-to order the actions of these two growth factor systems.
sis), but respectively in the coronary veins or renal veinsThus, it seems possible that the angiopoietin system
as well (Hollenberg, 1993). Why does endothelial DNAmay act upstream of ephrin-B2, but the reverse is also
synthesis in collateral arteries spread from the ischemicplausible. However, since angiopoietins and Ties do not
zone in a time-related retrograde gradient? Why doeshave asymmetric distributions, it seems unlikely that
a similar retrograde spread of endothelial labeling occurangiopoietins directly establish ephrin-B2/Eph-B4 ex-
along the spermatic artery when a tumor is implantedpression patterns, or vice versa. It also remains possible
in the rat testis (Hollenberg, 1993)?What is the molecularthat the ephrin and angiopoietin systems act in largely
mechanism of arteriovenous malformations in which ar-independent fashions, disruption of either of which leads
teries and veins overgrow in the apparent absence orto a similar phenotype. It has been suggested that the
deficiency of a normal intervening capillary bedÐanangiopoietins themselves may not be ªinstructiveº re-
anomaly that is distinct from venous malformation (Folk-modeling signals, but are simply ªpermissiveº in that
man and D'Amore 1996)? While tumors deploy angio-they allow for proper interactions between endothelial
genic proteins (e.g., VEGF and bFGF) to induce neovas-cells and supporting cells, resulting in a system that can
cularization at the level of the microcirculation, how dothen properly respond to other cues (Suri et al., 1996);
they stimulate growth of feeder arteries and veins thatephrin-B2 may be just such an instructive cue that re-
they often appear to ªparasitizeº from neighboring or-quires prior permissive actions of the angiopoietins.
gans? It is not clear whether ephrin-B2 and its receptorPossible Roles of the Ephrins
can help to explain some of these puzzles, but theyin Postnatal Angiogenesis
provide a starting point for experimental study.It is important to note that the demarcation of arterial
and venous vessels by reciprocal ephrin-B2 and Eph-
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